MDNews - Mid Penn

Innovation Edition 2016

Issue link: https://viewer.e-digitaledition.com/i/751011

Contents of this Issue

Navigation

Page 14 of 23

company Abbott. Absorb is referred to as a sca›old to indicate its temporar y n a t u r e , u n l i k e a p e r m a n e n t m e t a l l i c s t e n t . M a n y p a t i e n t s w i t h c o r o n a r y a r t e r y d i s e a s e o r blo cke d hea r t a r t er ie s a re t reat e d with permanent stents to help restore blood flow and then prop open the artery. Absorb works by restoring blood f low to the hea r t, keeping the vessel open unti l it ca n stay open on its ow n a nd then dissolving completely over time. Absorb dissolves except for two pairs of tiny meta llic markers, which help guide placement a nd rema in in t he a r ter y to enable a physicia n to see where the device was placed. " The Absorb BVS is impressive a nd combines t he unique at tr ibutes of a dissolvable materia l with best-in-class stent technolog y," Dr. Bachinsky says. " The Absorb device leaves behind no permanent meta llic stent in the arter y, unlike devices used commonly to treat corona r y a r ter y disease, a nd may help restore nat ura l vessel f unction . We a re for t u nate to have access to t h is cut t i n g- ed ge t ech nolog y r i g ht here in Ha rrisburg." Enrolling 2,008 patients with coro - na r y a r ter y disease — the majorit y in the U.S. — the study compared Abbott 's Absorb dev ice to the world's leading meta llic drug-eluting stent in a head- to-head tria l. PinnacleHea lth is one of only 10 hos- pita ls in the nation with the Absorb BVS ava ilable. The procedure is performed i n one of f ive c a rd i a c c at het er i z a- tion laborator ies at PinnacleHea lt h Ha r r isburg Hospita l. Each feat ures adva nced technolog y for the diagnosis a nd treatment of hea r t a nd va scu la r conditions, both emergency a nd elec- tive, including high-resolution v ideo screens a nd X-ray machines. T o r e f e r a p a t i e n t , p l e a s e c a l l P i n n a c l e H e a l t h C a r d i oVa s c u l a r In stitute at 7 17-731- 0101 . For more information about Absorb, please call Janine Brightbill, Physician Marketing Coordinator, at 717-231-8172 . ■ Leading-edge Care A DAY OR so before his hear t attack in July 2016, Ty realized he was straining to climb steps. In the middle of the night, he awoke having difficulty breathing and an odd tingling sensation in his elbows. At his wife's insistence, Ty drove himself to PinnacleHealth Community General Osteopathic Hospital, where clinical staff determined he was having a hear t attack. After Ty was stabilized and transferred to PinnacleHealth Harrisburg Hospital, Dr. Bachinsky opened his ar teries — Ty was the first in Pennsylvania to get the new dissolvable stent. Ty was discharged on the second day. Ty has never enjoyed exercising but realizes how much better he feels when he does exercise. He compliments the staff at PinnacleHealth Cardiac Rehab for motivating him. He is tr ying to do the right things: eat better and exercise. Ty says ever ything happened so quickly, but he realizes he is lucky to have made it safely to the hospital and to have gotten excellent care and the new device. He realizes he is for tunate to have more time with his wife and two children. Ty McCauslin of Harrisburg was the first patient in Pennsylvania to get the new dissolvable stent. Absorb Bioresorbable Vascular Scaffold PHOTO •C• ABBOTT GROUP OF COMPANIES M D N E W S . C O M /// M D N E W S M I D P E N N ■ 2 016 1 5 C L I N I C A L T R I A L S ❰❰❰❰❰ 1 5

Articles in this issue

Archives of this issue

view archives of MDNews - Mid Penn - Innovation Edition 2016